Cardiovascular risk factors: Belgian target achievementCardiovascular risk factors: Belgian target achievement
Faculty of Medicine and Health Sciences
Laboratory Experimental Medicine and Pediatrics (LEMP)
2014Brussels :Acta cardiologica, 2014
Acta cardiologica. - Bruxelles
69(2014):5, p. 473-481
University of Antwerp
Objective The objective of this study was to evaluate the level of target achievement for key modifiable cardiovascular disease (CVD) risk factors (dyslipidaemia, arterial hypertension, hyperglycaemia, smoking, and physical inactivity) in Belgium. Methods and results This non-systematic review of Belgian data from four recent studies assessed the control of CVD risk factors in clinical settings: the European Study on Cardiovascular Risk Prevention and Management in Usual Daily Practice (EURIKA), the Optimal Type 2 Diabetes Management Including Benchmarking and Standard Treatment Study (OPTIMISE), the European Action on Secondary and Primary Prevention by Intervention to Reduce Events Survey (EUROASPIRE III), and data from a general practice-based morbidity registration network (INTEGO). For each study, target achievement levels were evaluated using the guidelines that were applicable at the time of the study. The overall results show that the main CVD risk factors are poorly controlled in patients with established CVD and in patients at high CVD risk. Therapeutic targets may be incompletely reached because of the suboptimal implementation of European guidelines for CVD prevention in routine clinical practice (insufficient lifestyle and dietary adaptations; poor applications of drug therapy to control blood pressure, dyslipidaemia and hyperglycaemia) or the insufficient efficacy of the currently available treatments options in some patients. Conclusions This review provides clear and updated evidence for non-target achievement for all major risk factors, with four different study designs and inclusion criteria, and highlights the need for more comprehensive and intensive application of European guidelines recommendations for CVD prevention in Belgium.